Advertisement
BNTX vs CLDI
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BNTX is a Hold and CLDI is a StrongBuy.
BNTX in upward trend: price expected to rise as it breaks its lower Bollinger Band on October 13, 2026
BNTX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 31 of 39 cases where BNTX's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 79%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where BNTX's RSI Oscillator exited the oversold zone, 21 of 28 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 75%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The 50-day moving average for BNTX moved above the 200-day moving average on September 23, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a +2.33% 3-day Advance, the price is estimated to grow further. Considering data from situations where BNTX advanced for three days, in 180 of 263 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BNTX as a result. In 78 of 97 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 80%.
BNTX moved below its 50-day moving average on September 30, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for BNTX crossed bearishly below the 50-day moving average on October 01, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 8 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 53%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BNTX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 78%.
The Aroon Indicator for BNTX entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Seasonality Score of 1 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 12 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.269) is normal, around the industry mean (2.973). P/E Ratio (-13.364) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.046) is also within normal values, averaging (9.059). Dividend Yield (0.095) settles around the average of (128.121) among similar stocks. P/S Ratio (7.764) is also within normal values, averaging (438.009).
The Tickeron PE Growth Rating for this company is 36 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 70 (best 1 - 100 worst), indicating slightly worse than average price growth. BNTX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BNTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
CLDI in upward trend: price may ascend as a result of having broken its lower Bollinger Band on October 22, 2026
CLDI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 35 of 44 cases where CLDI's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 80%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 8 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 17 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Bearish Trend Analysis
The Moving Average Convergence Divergence Histogram (MACD) for CLDI turned negative on October 13, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In 23 of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at 53%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CLDI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for CLDI entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 61 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.633) is normal, around the industry mean (2.973). P/E Ratio (-0.021) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (438.009).
The Tickeron Price Growth Rating for this company is 94 (best 1 - 100 worst), indicating slightly worse than average price growth. CLDI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CLDI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
BNTX | ||
|---|---|---|
OUTLOOK RATING 1..100 | 71 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 12 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 93 | |
PRICE GROWTH RATING 1..100 | 70 | |
P/E GROWTH RATING 1..100 | 36 | |
SEASONALITY SCORE 1..100 | 1 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| BNTX | CLDI | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 75% | 1 day ago 72% |
| Stochastic ODDS (%) | 1 day ago 78% | 1 day ago 57% |
| Momentum ODDS (%) | 1 day ago 80% | N/A |
| MACD ODDS (%) | N/A | 1 day ago 53% |
| TrendWeek ODDS (%) | 1 day ago 77% | 1 day ago 82% |
| TrendMonth ODDS (%) | 1 day ago 76% | 1 day ago 89% |
| Advances ODDS (%) | 2 days ago 68% | N/A |
| Declines ODDS (%) | 9 days ago 78% | 1 day ago 90% |
| BollingerBands ODDS (%) | 1 day ago 79% | 1 day ago 80% |
| Aroon ODDS (%) | 1 day ago 76% | 1 day ago 90% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BNTX’s FA Score shows that 1 FA rating(s) are green while CLDI’s FA Score has 0 green FA rating(s).
- BNTX’s FA Score: 1 green, 4 red.
- CLDI’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BNTX’s TA Score shows that 5 TA indicator(s) are bullish while CLDI’s TA Score has 3 bullish TA indicator(s).
- BNTX’s TA Score: 5 bullish, 5 bearish.
- CLDI’s TA Score: 3 bullish, 3 bearish.
Price Growth
BNTX (@Biotechnology) experienced а +2.97% price change this week, while CLDI (@Biotechnology) price change was -12.13% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -1.10%. For the same industry, the average monthly price growth was -18.18%, and the average quarterly price growth was -15.20%.
Reported Earning Dates
BNTX is expected to report earnings on Nov 03, 2026.
CLDI is expected to report earnings on Nov 12, 2026.
Industries' Descriptions
@Biotechnology (-1.10% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
BNTX and
Correlation & Price change
A.I.dvisor indicates that over the last year, BNTX has been loosely correlated with MRNA. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if BNTX jumps, then MRNA could also see price increases.
| Ticker / NAME | Correlation To BNTX | 1D Price Change % | ||
|---|---|---|---|---|
| BNTX | 100% | -1.77% | ||
| MRNA - BNTX | 60% Loosely correlated | -17.57% | ||
| CRSP - BNTX | 45% Loosely correlated | -1.01% | ||
| AXON - BNTX | 43% Loosely correlated | +2.98% | ||
| NVAX - BNTX | 42% Loosely correlated | -9.26% | ||
| MRVI - BNTX | 41% Loosely correlated | -6.61% | ||
More | ||||
CLDI and
Correlation & Price change
A.I.dvisor indicates that over the last year, CLDI has been loosely correlated with TBPH. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CLDI jumps, then TBPH could also see price increases.
| Ticker / NAME | Correlation To CLDI | 1D Price Change % | ||
|---|---|---|---|---|
| CLDI | 100% | -15.38% | ||
| TBPH - CLDI | 46% Loosely correlated | N/A | ||
| PROK - CLDI | 32% Poorly correlated | -0.69% | ||
| BNTX - CLDI | 30% Poorly correlated | -1.77% | ||
| RYTM - CLDI | 29% Poorly correlated | +2.57% | ||
| MBIO - CLDI | 29% Poorly correlated | -2.84% | ||
More | ||||